New position statement on Diane-35 and VTE risk CLINICAL PEARLS: How to handle a fungal infection Apprilon: new once-daily oral therapy for rosacea Apprilon, marketed in the United States for several years under the brand name Oracea, is indicated for the treatment of inflammatory lesions of rosacea in adults. Keeping the itch at bay New clues into treating eczema Psoriasis doubles diabetes risk Researcher calls for annual screening in patients with the skin disease Add more allergens for patch testing Expanded series best for workplace-related contact dermatitis Ontario lags in tracking non-melanoma skin cancers Lack of data hampers research, resource allocation, dermatologist says Head lice: Picking out truth from myth Spray-on skin heals ulcers Here comes the sun Prevention and treatment of photoaging First Previous 41 42 43 44 45 Next Last
